JTJanpen Thonghlueng

Janpen Thonghlueng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Janpen Thonghlueng has a total of 31 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Amplification-Free Dual-Mode Gold Nanoparticle–Nanocluster Platform for Single-Nucleotide Discrimination of SMN1 in Spinal Muscular Atrophy Screening

    by Piyaporn Matulakul, Nathakrit Kasemsuk, Janpen Thonghlueng, Chantamalinee Chantarangkul, Suangsiri Arunlimsawat, Kamolnat Vangcom, Thanakit Sribut, Katawut Namdee, Vinich Promarak, Kanda Sornkayasit, et al.

    Spinal muscular atrophy (SMA) is a severe genetic disorder primarily caused by homozygous deletion of exon 7 in the SMN1 gene, leading to deficiency of the survival motor neuron (SMN) protein. Accurate detection of SMN1 is challenging because it is highly homologous to SMN2, differing at only a few nucleotides, most notably a single nucleotide substitution in exon 7 that affects splicing. Rapid and reliable detection of SMN1 exon 7 deletion is therefore essential for newborn screening; however, the high sequence homology between SMN1 and SMN2 necessitates highly specific assay designs, which can increase technical complexity in high-throughput workflows, including those based on dried blood spot (DBS) samples. Here, we report an amplification-free dual-mode nanoplasmonic biosensing platform capable of single-nucleotide discrimination based on hybrid interactions between cetyltrimethylammonium bromide-stabilized gold nanoparticles (CTAB-AuNPs) and glutathione-protected gold nanoclusters (GSH-AuNCs). Hybridization-regulated nanoparticle assembly modulates probe adsorption onto AuNPs and promotes interparticle interactions between CTAB-AuNPs and GSH-AuNCs, generating two correlated optical readouts: a ratiometric colorimetric response (A525/A650) arising from plasmonic coupling of AuNPs and fluorescence attenuation (ΔI) originating from the inner filter effect between AuNP absorption and AuNC fluorescence emission. The platform exhibits a linear response over 10–100 nM and achieves limits of detection of 7.29 and 6.12 nM for the colorimetric and fluorescence modes, respectively. Receiver operating characteristic (ROC) analysis demonstrates excellent single-nucleotide discrimination between SMN1 and SMN2, with area under the curve (AUC) values approaching 1.0, indicating high diagnostic accuracy even in complex genomic DNA (gDNA) matrices. The sensor also enables reliable detection in gDNA extracted from DBS samples, highlighting its potential for amplification-free genetic testing and decentralized SMA newborn screening.

  • Open Access

    In situ coffee ground-derived carbon dots as a sustainable antenna for photosynthesis enhancement: Experimental and DFT mechanistic insights

    by Janpen Thonghlueng, Wichian Sangwongchai, Adulvit Chuaephon, Pakawat Toomjeen, Piyaporn Matulakul, Pollasate Chune Terasart, Kreetha Apaisom, Vinich Promarak, Phatsathorn Chonlateeroj, Somlak Ittisanronnachai, et al.


  • Tryptophan-Conjugated Carbon Dots with Enhanced Cellular Uptake as a Potential Drug Delivery System for Melanoma

    by Nasrin Imumkachi, Pornpattra Rattanaseth, Sawinee Ngernpimai, Janpen Thonghlueng, Piyaporn Matulakul, Pakawat Toomjeen, Theerapong Puangmali, Raynoo Thanan, Tawut Rudtanatip, Natthida Weerapreeyakul, et al.

    Melanoma is a rare but highly aggressive form of skin cancer that can rapidly metastasize, leading to a significant mortality rate. A main challenge in chemotherapy is the lack of selectivity in drug delivery to tumor sites, which affects both tumor and healthy tissues. Developing drug delivery systems (DDS) capable of preferentially interacting with transporters expressed on cancer cells may help address this issue. Carbon dots (CDs) have emerged as promising tools for the advancement of DDS due to their distinctive fluorescent characteristics, good water solubility, biocompatibility, and straightforward fabrication. In this work, CDs were synthesized via a facile method and conjugated with tryptophan (Trp) to evaluate their potential application as a DDS in melanoma. The fabricated CDs were characterized for their size, surface charge, optical properties, functional groups, and elemental analysis. LAT1 expression was examined by immunofluorescence, confirming higher levels in SK-MEL-2 melanoma cells compared to HK-2 normal kidney cells. Biocompatibility was established before conjugating CDs with tryptophan (Trp), ditryptophan (di-Trp), and tritryptophan (tri-Trp) and assessing their size, functional groups, and optical characteristics. Cellular uptake studies showed preferential uptake of Trp-conjugated CDs in SK-MEL-2 cells over HK-2 cells, indicating that tri-Trp-CDs exhibited the highest uptake. Molecular dynamics simulations suggested potential CDs-LAT1 interactions via van der Waals and electrostatic interactions. Trp-conjugated CDs were biocompatible with both SK-MEL-2 and HK-2 cells and could be electrostatically loaded with doxorubicin (DOX), exhibiting enhanced cytotoxicity against SK-MEL-2 cells compared to DOX alone. A trend toward greater selectivity for SK-MEL-2 cells over normal cells was observed, with tri-Trp/DOX showing the most pronounced effect, possibly reflecting LAT1-1 mediated uptake. These findings suggest that Trp-modified CDs may serve as promising DDS candidates for melanoma treatment.